232 related articles for article (PubMed ID: 16127052)
81. Cloning and characterization of an Mx gene and its corresponding promoter from the zebrafish, Danio rerio.
Altmann SM; Mellon MT; Johnson MC; Paw BH; Trede NS; Zon LI; Kim CH
Dev Comp Immunol; 2004 Apr; 28(4):295-306. PubMed ID: 14698216
[TBL] [Abstract][Full Text] [Related]
82. Identification of the major positional isomer of pegylated interferon alpha-2b.
Wang YS; Youngster S; Bausch J; Zhang R; McNemar C; Wyss DF
Biochemistry; 2000 Sep; 39(35):10634-40. PubMed ID: 10978146
[TBL] [Abstract][Full Text] [Related]
83. The MxA protein levels in whole blood lysates of patients with various viral infections.
Chieux V; Hober D; Harvey J; Lion G; Lucidarme D; Forzy G; Duhamel M; Cousin J; Ducoulombier H; Wattré P
J Virol Methods; 1998 Feb; 70(2):183-91. PubMed ID: 9562412
[TBL] [Abstract][Full Text] [Related]
84. A sensitive biological assay for interferons.
Lewis JA
J Immunol Methods; 1995 Sep; 185(1):9-17. PubMed ID: 7665903
[TBL] [Abstract][Full Text] [Related]
85. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon.
Roers A; Hochkeppel HK; Horisberger MA; Hovanessian A; Haller O
J Infect Dis; 1994 Apr; 169(4):807-13. PubMed ID: 7510764
[TBL] [Abstract][Full Text] [Related]
86. Somnogenic effects of rabbit and recombinant human interferons in rabbits.
Kimura M; Majde JA; Toth LA; Opp MR; Krueger JM
Am J Physiol; 1994 Jul; 267(1 Pt 2):R53-61. PubMed ID: 7519411
[TBL] [Abstract][Full Text] [Related]
87. An in vitro bioassay for quantitation of human interferons by measurements of antiproliferative activity on a continuous human lymphoma cell line.
Nederman T; Karlström E; Sjödin L
Biologicals; 1990 Jan; 18(1):29-34. PubMed ID: 2317351
[TBL] [Abstract][Full Text] [Related]
88. Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.
Ching JC; Chan KY; Lee EH; Xu MS; Ting CK; So TM; Sham PC; Leung GM; Peiris JS; Khoo US
J Infect Dis; 2010 Jun; 201(12):1899-908. PubMed ID: 20462354
[TBL] [Abstract][Full Text] [Related]
89. Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection.
Li SF; Gong MJ; Zhao FR; Shao JJ; Xie YL; Zhang YG; Chang HY
Cell Physiol Biochem; 2018; 51(5):2377-2396. PubMed ID: 30537741
[TBL] [Abstract][Full Text] [Related]
90. Biological properties of interferon-alpha produced Ex vivo by whole blood of patients infected by human immunodeficiency virus-1.
Chehadeh W; Hober D; Chieux V; Alm G; Harvey J; Lion G; Mouton Y; Wattré P
Scand J Immunol; 1999 Jun; 49(6):660-6. PubMed ID: 10354379
[TBL] [Abstract][Full Text] [Related]
91. MxA-independent inhibition of Hantaan virus replication induced by type I and type II interferon in vitro.
Oelschlegel R; Krüger DH; Rang A
Virus Res; 2007 Jul; 127(1):100-5. PubMed ID: 17482705
[TBL] [Abstract][Full Text] [Related]
92. Promoter structure of the MxA gene that confers resistance to influenza virus.
Nakade K; Handa H; Nagata K
FEBS Lett; 1997 Dec; 418(3):315-8. PubMed ID: 9428735
[TBL] [Abstract][Full Text] [Related]
93. MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes.
Weber F; Haller O; Kochs G
J Virol; 2000 Jan; 74(1):560-3. PubMed ID: 10590150
[TBL] [Abstract][Full Text] [Related]
94. Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.
Scagnolari C; Casato M; Bellomi F; De Pisa F; Turriziani O; Coviello R; Pirro MR; Dianzani F; Antonelli G
Clin Diagn Lab Immunol; 2003 Jan; 10(1):70-7. PubMed ID: 12522042
[TBL] [Abstract][Full Text] [Related]
95. Perspectives of pegylated interferon use in dermatological oncology.
Pehamberger H
Recent Results Cancer Res; 2002; 160():158-64. PubMed ID: 12079210
[TBL] [Abstract][Full Text] [Related]
96. Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients.
Gilli F; Sala A; Bancone C; Salacone P; Gallo M; Gaia E; Bertolotto A
J Immunol Methods; 2002 Apr; 262(1-2):187-90. PubMed ID: 11983232
[TBL] [Abstract][Full Text] [Related]
97. Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues.
Spolaore B; Raboni S; Satwekar AA; Grigoletto A; Mero A; Montagner IM; Rosato A; Pasut G; Fontana A
Bioconjug Chem; 2016 Nov; 27(11):2695-2706. PubMed ID: 27731976
[TBL] [Abstract][Full Text] [Related]
98. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein.
Rosmorduc O; Sirma H; Soussan P; Gordien E; Lebon P; Horisberger M; Br Chot C; Kremsdorf D
J Gen Virol; 1999 May; 80 ( Pt 5)():1253-1262. PubMed ID: 10355772
[TBL] [Abstract][Full Text] [Related]
99. A bioassay for interferon type I based on inhibition of Sendai virus growth.
Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW
J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385
[TBL] [Abstract][Full Text] [Related]
100. Rapid Reversible Osmoregulation of Cytoplasmic Biomolecular Condensates of Human Interferon-α-Induced Antiviral MxA GTPase.
Sehgal PB; Yuan H; Jin Y
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
